MedPage Today August 6, 2022
— Broader representation can help address health disparities and improve patient outcomes
The COVID-19 pandemic sparked rapid innovation and adoption of new methodologies and practices across clinical trials. It also allowed the world to see the difficulty of ensuring diversity and access to those trials — a challenge we’ve faced for many years. Innovators in biopharma, life-science technology companies, and clinical research organizations (CROs) partnered with the FDA and health regulators around the world to successfully meet this enormous challenge. But we need to keep our foot on the gas.
It’s time to press ahead with meaningful, durable change — to codify the lessons we’ve learned during the COVID pandemic, amplify what worked, and harmonize the regulatory environment to promote...
Today's Sponsors
Today's Sponsor